Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
03/2002
03/21/2002WO2002022607A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022606A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022605A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022604A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022603A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022602A2 Triazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022601A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022600A2 Chemokine receptor binding heterocyclic compounds
03/21/2002WO2002022599A2 Chemokine receptor binding heterocyclic compounds
03/21/2002WO2002022587A1 Pyridazinones and triazinones and medicinal use thereof
03/21/2002WO2002022577A2 Hydroxamate derivatives useful as deacetylase inhibitors
03/21/2002WO2002022129A1 A method of analgesia
03/21/2002WO2002006361A3 Novel photochromic polymers and methods of synthesizing same
03/21/2002WO2002004457A8 Azepino[4,5-b]pyrano[3,2-e]indoles
03/21/2002WO2001087846A3 Tricyclic pyrazole derivatives as protein kinase inhibitors
03/21/2002WO2001064715A3 Memno peptides, a process for their preparation and their use
03/21/2002US20020034761 Methods of labelling polynucleotides with dibenzorhodamine dyes
03/21/2002US20020034730 For identifying compounds that bind to ion channel and may have antiarrhythmic activity
03/21/2002CA2742411A1 Pyridazinone and triazinone compounds and use thereof as pharmaceutical preparations
03/21/2002CA2419224A1 Chemokine receptor binding heterocyclic compounds
03/21/2002CA2419219A1 Chemokine receptor binding heterocyclic compounds
03/20/2002EP1188747A1 Phenoxypropylamine compounds
03/20/2002EP1187835A1 Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof
03/20/2002EP1187810A2 Heterocyclic analgesic compounds and their use
03/20/2002EP0888356B1 Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
03/19/2002US6359151 Use as pesticides.
03/19/2002US6359111 Useful in treating cancer, and in a method of imaging opioid receptors either inside or outside of the central nervous system
03/19/2002US6358966 Using 1-(4-(1-(4-fluorophenyl)-1h-indole-3-yl)-1-butyl spiro(isobenzofuran-1(3h,4-piperidine)
03/19/2002US6358887 2-Phenyl-substituted heterocyclic 1,3-ketonols as herbicides and pesticides
03/19/2002US6358634 Nitrogen-containing heterocyclic compound, organic light-emitting device material and organic light-emitting device
03/19/2002CA2128359C New benzospiroalkene derivatives, their preparation process and pharmaceutical compositions containing them
03/19/2002CA2128287C Benzospiroalkene derivatives, their preparation process and pharmaceutical compositions containing them
03/19/2002CA2079548C Carbamate derivatives of 4-amino-3- isoxazolidinones, 3-amino-1- hydroxypyrrolidin-2-ones and 1-amino-1- cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments
03/14/2002WO2002020509A2 Medicaments against viral infections
03/14/2002WO2002020489A2 QUINOLINE INHIBITORS OF cGMP PHOSPHODIESTERASE
03/14/2002WO2002020484A1 Chemical compounds
03/14/2002US20020032326 Treating mammalian leukemia; lung carcinoma; colon adenocarcinoma malignant melanoma; assaying the human cytochrome CYP3A4 metabolism of ecteinascidin 743
03/14/2002DE10043791A1 Antiviral medicaments containing new or known chroman-4-one or chroman-4-one derivatives, especially effective against hepatitis B virus infections
03/14/2002DE10042137A1 sgk2 und sgk3 als diagnostische und therapeutische Targets sgk2 and sgk3 as diagnostic and therapeutic targets
03/13/2002EP1185536A2 Hemisynthetic method and intermediates thereof
03/13/2002EP1185533A1 Naphthopyrans annelated in c5-c6 with a lactam-type c6 ring and compositions and (co)polymer containing them
03/13/2002EP1185275A1 Aminopyrimidines as sorbitol dehydrogenase inhibitors
03/13/2002EP0764025B1 Method and medicine for alleviating jet lag
03/13/2002EP0596897B1 Hydroisoquinoline derivatives
03/13/2002CN1080719C Substituted 1H-3-aryl-pyrrolidine-2,4-diones derivatives
03/07/2002WO2002018370A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
03/07/2002WO2002017923A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
03/07/2002WO2002017893A2 Sgk2 and sgk3 used as diagnostic and therapeutic targets
03/07/2002WO2002017712A2 Disubstituted benzenes as insecticides
03/07/2002WO2001077100A3 Benzoamide piperidine compounds as substance p antagonists
03/07/2002US20020028829 Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
03/07/2002US20020028815 Novel multicyclic compounds and the use thereof
03/07/2002US20020028813 Isoquinoline inhibitors of the nucleic enzyme poly(adenosine 5'-diphospho-ribose) polymerase (PARP); treat tissue damage from necrosis or apoptosis, ischemia or reperfusion injury, stroke, senescence diseases
03/07/2002US20020028802 Solvent extraction; plant extracts
03/07/2002US20020028464 Diagnosis of diabetes
03/07/2002DE10042061A1 Bicyclische Heterocyclen,diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation
03/07/2002DE10042059A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation
03/07/2002CA2420804A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
03/07/2002CA2419472A1 Sgk2 and sgk3 used as diagnostic and therapeutic targets
03/07/2002CA2417042A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
03/06/2002EP1184379A1 Chromene compound
03/06/2002EP1183239A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
03/06/2002EP0876372B1 Heteroarylcarboxamide derivatives
03/06/2002EP0854873B1 Galanthamine derivatives and process for their preparation
03/06/2002EP0695296B1 3-aryloxy carboxylic acid derivatives and method of preparing them
03/06/2002EP0695295B1 3-(hetero)aryl carboxylic acid derivatives, methods of preparing them and intermediates used in their preparation
03/06/2002CN1080258C 1-H-3-arylpyrrolidine-2,4-dione derivatives as pest-control agents
03/05/2002US6353107 1-alkoxy-polyallkyl-piperidine derivatives and their use as polymerization regulators
03/05/2002US6353002 Therapeutic agents
03/05/2002US6352999 Drugs for nervous system disorders, parkinson's disease and antidepressants
03/05/2002US6352996 Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
03/05/2002US6352995 Spiro-quinuclidine derivatives, their preparation and use
03/05/2002US6352988 High affinity for d4 receptors; treatment of schizophrenia, other psychoses, anxiety disorders, depression, alcohol abuse, impulse control disorders, aggression
03/05/2002US6352954 Microencapsulated lewis acid
02/2002
02/28/2002WO2002016369A2 Novel macrocycles and uses thereof
02/28/2002WO2002015909A1 Substituted piperidines as melanocortin receptor agonists
02/28/2002WO2002015906A1 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon
02/28/2002WO2001092255A3 Epothilone derivatives and methods for making and using the same
02/28/2002US20020026059 Use as microbicides in crop protection
02/28/2002US20020025962 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
02/28/2002CA2420235A1 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon
02/28/2002CA2419310A1 Substituted piperidines as melanocortin receptor agonists
02/27/2002EP1182200A1 Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
02/27/2002EP1181935A2 Agent for treating mental disorders associated with cerebrovascular disorders
02/27/2002EP1181335A1 Extended rhodamine compounds useful as fluorescent labels
02/27/2002EP1181294A1 Novel derivatives and analogues of galanthamin
02/27/2002EP1181279A1 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof
02/27/2002EP0587645B1 Benzo- and pyridopyran derivatives having anxiolytic and anti-convulsant activity
02/27/2002CN1337964A Novel aralkyl amines of spirofuropyridines useful in therapy
02/27/2002CN1337932A Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treamtent of respiratory diseases
02/27/2002CN1079798C 3-aryl-tetronic acid derivatives, the production thereof and the use thereof as antiparasitic agents, and the intermediate
02/27/2002CN1079797C Crystal of dihydrate of fused tricyclic compound, process for preparation thereof and its use
02/26/2002US6350770 Microbiocides, insecticides
02/26/2002US6350762 Dihydropyridine derivative
02/26/2002US6350756 Useful for treating cancer; (20s) esters with an oxyalkanoic acid;
02/26/2002CA2128119C Benzospiroalkene derivatives, process for their preparation and pharmaceutical compositions containing them
02/21/2002WO2002014324A2 Diazepinones as antiviral agents
02/21/2002WO2002014323A2 Polymorphs of an epothilone analog
02/21/2002WO2002014311A2 Urea compounds and methods of uses
02/21/2002WO2002014273A1 Indoline derivatives as 5ht2c antagonists